June 2026 GEA introduced the CONRAD® Freeze Dryer, a next-generation pharmaceutical lyophilization platform designed to improve energy efficiency, process flexibility, and GMP compliance for biologics manufacturing. The new system incorporates advanced process automation and scalable configurations to support commercial pharmaceutical production across Europe.
March 2026 Syntegon expanded its pharmaceutical processing portfolio with enhancements to its Lyomax freeze dryer platform, incorporating advanced process analytical technologies (PAT) and automated loading systems to improve lyophilization efficiency. The upgrade supports high-throughput sterile pharmaceutical manufacturing facilities across Europe.
November 2025 Telstar (Azbil Group) launched the LYO-Gamma laboratory freeze dryer series for pharmaceutical and biotechnology applications. The product launch introduced enhanced process control, data integrity features, and scalable cycle development capabilities to support R&D and pilot-scale lyophilization.
October 2025 GEA partnered with a leading European pharmaceutical manufacturer to deploy advanced freeze-drying technology for sterile injectable drug production. The collaboration focused on increasing manufacturing capacity while improving energy efficiency and process reliability through automated lyophilization systems.